In last trading session, Cara Therapeutics Inc (NASDAQ:CARA) saw 22.95 million shares changing hands with its beta currently measuring 0.68. Company’s recent per share price
Cara Therapeutics Inc (NASDAQ:CARA) has a beta value of 0.68 and has seen 1.38 million shares traded in the last trading session. The company, currently
In the last trading session, 1.01 million shares of the Cara Therapeutics Inc (NASDAQ:CARA) were traded, and its beta was 0.68. Most recently the company’s
Cara Therapeutics Inc (NASDAQ:CARA)’s traded shares stood at 0.57 million during the last session, with the company’s beta value hitting 0.68. At the close of
In last trading session, Cara Therapeutics Inc (NASDAQ:CARA) saw 0.32 million shares changing hands with its beta currently measuring 0.63. Company’s recent per share price
During the last session, Cara Therapeutics Inc (NASDAQ:CARA)’s traded shares were 0.51 million, with the beta value of the company hitting 0.65. The 52-week high
In today’s recent session, 0.5 million shares of the Cara Therapeutics Inc (NASDAQ:CARA) have been traded, and its beta is 0.65. Most recently the company’s
In last trading session, Cara Therapeutics Inc (NASDAQ:CARA) saw 1.36 million shares changing hands with its beta currently measuring 0.64. Company’s recent per share price
During the last session, Cara Therapeutics Inc (NASDAQ:CARA)’s traded shares were 2.23 million, with the beta value of the company hitting 0.69. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
